Greenlight Capital’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Greenlight Capital’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$6K	Hold	100,000	–	–	﹤0.01%	39
2023 Q3	$10K	Hold	100,000	–	–	﹤0.01%	37
2023 Q2	$16.5K	Hold	100,000	–	–	﹤0.01%	39
2023 Q1	$12K	Hold	100,000	–	–	﹤0.01%	38
2022 Q4	$14.4K	Hold	100,000	–	–	﹤0.01%	39
2022 Q3	$20K	Hold	100,000	–	–	﹤0.01%	40
2022 Q2	$28K	Hold	100,000	–	–	﹤0.01%	45
2022 Q1	$81K	Hold	100,000	–	–	0.01%	49
2021 Q4	$189K	Hold	100,000	–	–	0.01%	49
2021 Q3	$256K	Hold	100,000	–	–	0.02%	49
2021 Q2	$260K	Hold	100,000	–	–	0.02%	61
2021 Q1	$267K	Buy	+100,000	New	+$289K	0.02%	54

Other funds holding NUVB.WS

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return